A comparison study of three different methods of neuroendocrine tumor (NET) detection that includes PET/CT, SPECT/CT and whole body MR imaging places PET/CT with gallium-68 (Ga-68) DOTATATE on a pedestal above the rest for its sensitivity in finding NETs, according to a study published Aug. 28 in the Journal of Nuclear Medicine . {read more here}

Advanced Accelerator Applications (AAA) announced today that it has acquired GE Healthcare’s FDG-PET radiopharmaceutical division in Italy. {read more here}

Nearly a year ago, the Centers for Medicare & Medicaid Services denied coverage for an Eli Lilly LLY +0.10%imaging agent to be used in diagnosing Alzheimer’s. In reaching its decision, CMS cited a lack of evidence that the agent, called Amyvid, could improve health outcomes. As a result, CMS greatly narrowed the potential use of the agent, dealing Lilly a significant setback. {read more here}

Obese people actually may get less pleasure out of eating than their slimmer counterparts, according to new research from the National Institutes of Health. The new study, published in Molecular Psychiatry, using PET Scanning the researchers found more dopamine activity in obese participants’ brain regions associated with habit-forming, and less activity in the areas associated with reward, when compared to their slimmer counterparts. {read more here}